{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:31Z","timestamp":1787026951753,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1911A , 01GM2207A"],"award-info":[{"award-number":["01GM1911A , 01GM2207A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>GATA2 deficiency is one of the most common genetic predispositions to pediatric myelodysplastic syndrome (MDS) in children and adolescents. The wide spectrum of disease comprises, among others, hematological, immunological and pulmonary manifestations, as well as occasionally distinct organ anomalies. Due to the elevated risk of progression, nearly all individuals with GATA2-related MDS eventually undergo a hematopoietic stem cell transplantation (HSCT) at some point in their lives. Nevertheless, the optimal timing, method, and even the indication for HSCT in certain cases are still matter of debate and warrant further research. In this article, we report five patients with different hematological and immunological manifestations of GATA2 deficiency ranging from immunodeficiency and refractory cytopenia of childhood without chromosomal aberrations to relapsed MDS-related acute myeloid leukemia. We discuss the adopted strategies, including intensity of surveillance, indication and timing of HSCT, based on morphological, clinical and molecular markers, as well as individual patient needs. We conclude that a better characterization of the natural disease course, a better understanding of the prognostic significance of somatic aberrations and a thorough evaluation of patients\u00b4 perspectives and preferences are required to achieve a personalized approach aimed at improving the care of these patients.<\/jats:p>","DOI":"10.3389\/fonc.2024.1423856","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:41:54Z","timestamp":1719448914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The different faces of GATA2 deficiency: implications for therapy and surveillance"],"prefix":"10.3389","volume":"14","author":[{"given":"Luca","family":"Vinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38142","article-title":"Childhood cancer predisposition syndromes\u2014A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology","volume":"173","author":"Ripperger","year":"2017","journal-title":"Am J Med Genet Part A"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-022-03447-9","article-title":"The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia","volume":"482","author":"Rudelius","year":"2023","journal-title":"Virchows Archiv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01374-y","article-title":"Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome","volume":"56","author":"Bortnick","year":"2021","journal-title":"Bone Marrow Transplantation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.297","article-title":"Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study","volume":"25","author":"Strahm","year":"2011","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30530","article-title":"Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disorders","volume":"70","author":"Wachter","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-765214","article-title":"How I treat myelodysplastic syndromes of childhood","volume":"131","author":"Locatelli","year":"2018","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-837336","article-title":"A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing","volume":"132","author":"Wehr","year":"2018","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0899-5","article-title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","volume":"34","author":"Kozyra","year":"2020","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.01.005","article-title":"Pneumocystis jiroveci pneumonia and GATA2 deficiency: Expanding the spectrum of the disease","volume":"74","author":"Gonz\u00e1lez-Lara","year":"2017","journal-title":"J Infection"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"haematologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Nov\u00e1kov\u00e1","year":"2016","journal-title":"haematologica"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017764","article-title":"The spectrum of GATA2 deficiency syndrome","volume":"141","author":"Calvo","year":"2023","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8305","DOI":"10.1038\/s41598-020-64852-1","article-title":"A panoply of rheumatological manifestations in patients with GATA2 deficiency","volume":"10","author":"Amarnani","year":"2020","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-844654","article-title":"The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","article-title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","volume":"102","author":"Kardos","year":"2003","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705730","article-title":"Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood","volume":"40","author":"Strahm","year":"2007","journal-title":"Bone Marrow Transplantation"},{"key":"B21","first-page":"1","article-title":"Guidelines for hematopoietic stem cell transplantation (HSCT) in childhood MDS and JMML for patients enrolled in EWOG-MDS studies","year":"2017","journal-title":"In Freiburg;"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861070","article-title":"Donor-derived MDS\/AML in families with germline GATA2 mutation","volume":"132","author":"Galera","year":"2018","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865773","article-title":"GATA 2 deficiency: focus on immune system impairment","volume":"13","author":"Fabozzi","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1007\/s10875-023-01583-8","article-title":"A nationwide study of GATA2 deficiency in Italy reveals novel symptoms and genotype\u2013phenotype association","volume":"43","author":"Roncareggi","year":"2023","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","article-title":"ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome","volume":"6","author":"West","year":"2022","journal-title":"Blood Advances"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.342","article-title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","volume":"31","author":"Pastor","year":"2017","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019425","article-title":"The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia","volume":"141","author":"Hakkarainen","year":"2023","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30977","article-title":"2024 ASPHO conference papers and posters","volume":"71","author":"Attardi","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178587","article-title":"Correlation between peripheral blood and bone marrow somatic mutations among patients with suspected or established myelodysplastic syndromes from the national MDS study","volume":"142","author":"DeZern","year":"2023","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.3390\/cancers15235594","article-title":"Development of MDS in pediatric patients with GATA2 deficiency: increased histone trimethylation and deregulated apoptosis as potential drivers of transformation","volume":"15","author":"Schreiber","year":"2023","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1182\/bloodadvances.2023010113","article-title":"Venetoclax-based therapies in pediatric advanced MDS and relapsed\/refractory AML: a multicenter retrospective analysis","volume":"7","author":"Masetti","year":"2023","journal-title":"Blood Adv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.clim.2020.108522","article-title":"Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis","volume":"218","author":"van Lier","year":"2020","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000271","article-title":"Mechanisms of somatic transformation in inherited bone marrow failure syndromes","volume":"2021","author":"Choijilsuren","year":"2021","journal-title":"Hematology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2022.07.002","article-title":"Somatic compensation of inherited bone marrow failure","volume":"59","author":"Lundgren","year":"2022","journal-title":"Semin Hematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/asheducation-2017.1.96","article-title":"Treatment of inherited bone marrow failure syndromes beyond transplantation","volume":"2017","author":"Calado","year":"2017","journal-title":"Hematology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1423856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T04:06:12Z","timestamp":1736481972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1423856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":39,"alternative-id":["10.3389\/fonc.2024.1423856"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1423856","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"article-number":"1423856"}}